Note 2 - Notes Receivable |
3 Months Ended |
|---|---|
Mar. 31, 2017 | |
| Notes to Financial Statements | |
| Loans, Notes, Trade and Other Receivables Disclosure [Text Block] |
Note 2: Notes ReceivableEffective July 2012, the Company sold a company-owned clinic, including the license agreement, equipment, and customer base, in exchange for a $90,000 unsecured promissory note. The note bore interest at 6% per annum for fifty -four months and requires monthly principal and interest payments over forty -two months, beginning on August 2013. The note matured in January 2017 and was paid in full upon maturity. Effective July 2015, the Company entered into two license transfer agreements, in exchange for $10,000 and $29,925 in separate unsecured promissory notes. The non-interest bearing notes require monthly principal payments over 24 months, beginning on September 1, 2015 and maturing on August 1, 2017.
Effective May 2016, the Company entered into three license transfer agreements, in exchange for three separate $7,500 unsecured promissory notes. The non-interest bearing notes require monthly principal payments over six months, beginning on May 1, 2017 and maturing on October 1, 2017. The net outstanding balance of the notes as of
March 31, 2017 and December 31, 2016 were $30,818 and $40,826, respectively. |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|